MRMelisa D. Marquioni Ramella

Melisa D. Marquioni Ramella

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melisa D. Marquioni Ramella has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Angela M. Suburo

    Universidad Austral

    5 shared publications
  • Tomás P. Bachor

    Instituto de Investigaciones en Medicina Traslacional (IIMT), Universidad Austral-CONICET, B1629AHJ, Pilar, Argentina

    3 shared publications
  • Angela M. Suburo

    Facultad de Ciencias Biomedicas, Universidad Austral, Pilar, Argentina

    2 shared publications
  • Mariela C. Marazita

    Instituto de Investigaciones en Medicina Translational (IIMT), Facultad de Ciencias Biomédicas, Universidad Austral, CONICET, Pilar, B1629AHJ, Buenos Aires, Argentina

    2 shared publications
  • Marisa A. Cubilla

    Instituto de Investigaciones en Medicina Translational (IIMT), Facultad de Ciencias Biomédicas, Universidad Austral, CONICET, Pilar, B1629AHJ, Buenos Aires, Argentina

    2 shared publications
  • Vicente Bermúdez

    Laboratorio de Biología del Cáncer, Instituto de Investigaciones Bioquímicas de Bahía Blanca (INIBIBB), Universidad Nacional del Sur (UNS)-CONICET, Dpto. de Biología, Bioquímica y Farmacia (UNS), Bahía Blanca 8000, Argentina

    2 shared publications

Latest Publications

  • Glucocorticoid and progesterone mechanisms in photoreceptor survival

    by Melisa D. Marquioni-Ramella, Marisa A. Cubilla, Vicente Bermúdez, Pablo S. Tate, Mariela C. Marazita, Angela M. Suburo


  • Early ciliary and prominin-1 dysfunctions precede neurogenesis impairment in a mouse model of type 2 diabetes

    by Tomás P. Bachor, Jana Karbanová, Edgar Büttner, Vicente Bermúdez, Melisa Marquioni-Ramella, Peter Carmeliet, Denis Corbeil, Angela M. Suburo


  • Open Access

    Photo-damage, photo-protection and age-related macular degeneration

    by Melisa D. Marquioni-Ramella, Angela M. Suburo

    Age-related macular degeneration (AMD) is a degenerative retinal disease that causes blindness in people 60–65 years and older, with the highest prevalence appearing in people 90 years-old or more. Epidemiological estimates indicate that the number of cases is increasing, and will almost double in the next 20 years. Preventive measures require precise etiological knowledge. This is quite difficult, since AMD is a multifactorial condition with intricate relationships between causes and risk factors. In this review, we describe the impact of light on the structure and physiology of the retina and the pigment epithelium, taking into account the continuous exposure to natural and artificial light sources along the life of an individual. A large body of experimental evidence demonstrates the toxic effects of some lighting conditions on the retina and the pigment epithelium, and consensus exists about the importance of photo-oxidation phenomena in the causality chain between light and retinal damage. Here, we analyzed the transmission of light to the retina, and compared the aging human macula in healthy and diseased retinas, as shown by histology and non-invasive imaging systems. Finally, we have compared the putative retinal photo-sensitive molecular structures that might be involved in the genesis of AMD. The relationship between these compounds and retinal damage supports the hypothesis of light as an important initiating cause of AMD.


  • Sitagliptin protects proliferation of neural progenitor cells in diabetic mice

    by Tomás P. Bachor, Melisa D. Marquioni-Ramella, Angela M. Suburo

    Sitagliptin (SIT) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the effects of incretin hormones, such as Glucose-dependent Insulinotropic Peptide (also known as Gastric Inhibitory Polypeptide, GIP) and Glucagon-Like Peptide 1 (GLP-1). We have now evaluated the effect of SIT on proliferation of neural progenitors in diabetic mice. A condition resembling the non-obese type 2 diabetes mellitus (D2) was achieved by a combination of streptozotocin and nicotinamide (NA-STZ), whereas a type 1-like disease (D1) was provoked by STZ without NA. Non-diabetic mice received vehicle injections. Cell proliferation was estimated by bromodeoxyuridine (BrdU) incorporation in two different regions of the subventricular zone (SVZ), the largest reserve of neural stem cells in the adult brain. SIT treatment did not modify the high fasting blood glucose (BG) levels and intraperitoneal glucose tolerance test (IPGTT) of D1 mice. By contrast, in D2 mice, SIT treatment significantly reduced BG and IPGTT. Both D1 and D2 mice showed a substantial reduction of BrdU labeling in the SVZ. Remarkably, SIT treatment improved BrdU labeling in both conditions. Our findings suggest that SIT would protect proliferation of neural progenitor cells even in the presence of non-controlled diabetic alterations.


  • Open Access

    Endothelin receptor A antagonist enhances light-induced damage in the mouse retina

    by Vicente Bermudez, Melisa D. Marquioni Ramella, Angela M. Suburo

  • Open Access

    Mifepristone, a Blocker of Glucocorticoid Receptors, Promotes Photoreceptor Death

    by Marisa A. Cubilla, Vicente Bermúdez, Melisa D. Marquioni Ramella, Tomás P. Bachor, Angela M. Suburo

    Purpose. Glucocorticoids are best known by their protective effect on retinal photoreceptor damage. However, they could also be involved in photoreceptor homeostasis under basal, nonstressful conditions. Therefore, we aimed to study glucocorticoid-induced changes of survival-related molecules in male mice retinas under standard illumination conditions (12 hours light, ≤ 60 lux/12 h dark). Methods. Male Balb-c mice were injected with dexamethasone (DEX), a selective glucocorticoid receptor α (GRα) agonist, its antagonist mifepristone (MFP), or both drugs (D+M) at noon. A group of mice was subjected to surgical adrenalectomy (AdrX). Retinas were studied by histology, immunohistochemistry, TUNEL procedure, and Western blotting at different periods after pharmacological or surgical intervention (6 hours, 48 hours, or 7 days). Results. The antiapoptotic molecule Bcl-XL significantly increased 6 hours after DEX injection. By contrast, this molecule could no longer be found after MFP injection. At the same time, high levels of cleaved caspase-3 (CC-3) and Bax appeared in retinal extracts, and TUNEL+ nuclei selectively showed in the outer nuclear layer (ONL). After MFP, retinal extracts also contained phosphorylated histone H2AX (p-H2AX), a marker of DNA breakage and repair. Loss of ONL nuclear rows and decrease of rhodopsin levels were evident 7 days after MFP administration. These changes were minimized when DEX was given together with MFP (D+M). In the absence of MFP, DEX increased Bcl-XL in every retinal layer, with a marked intensification in photoreceptor inner segments. Numerous TUNEL+ nuclei rapidly appeared in the ONL after AdrX. Conclusions. A single dose of MFP induced selective photoreceptor damage in the absence of other environmental stressors. Because damage was prevented by DEX, and was reproduced by AdrX, our findings suggest that glucocorticoids play a critical role in photoreceptor survival.